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Introduction
The MidSouth Computational Biology and Bioinformatics
Society held its twelfth annual conference at the Little
Rock Downtown Marriott and Statehouse Convention
Center in Little Rock, Arkansas on March 13-14, 2015
(MCBIOS 2015). This year’s theme was “Emerging Trends
in Bioinformatics“. The President and Conference
Co-Chair this year was Cesar M. Compadre who is a Pro-
fessor in the Department of Pharmaceutical Sciences at
the University of Arkansas for Medical Sciences (UAMS).
The other co-chair was William Slikker Jr., the director of
the FDA’s National Center for Toxicological Research.
Conference committee members were Elizabeth Pierce,
Shraddha Thakkar, Dennis Burian, Roger Perkins, Weida
Tong, Mary Yang, Shweta S. Chawan, Ping Fong Jr.,
Galina Glazko, Mihir Jaiswal, and Paola Ordonez. Shrad-
dha Thakkar was chosen as President-Elect for 2016-7.
There were 158 registrants and a total of 141 abstracts
submitted (60 oral and 81 poster presentations).
Keynote speakers were: Carolina Cruz-Neira, the Direc-
tor of the Emerging Analytics Center at the University of
Arkansas at Little Rock (title: “The Pretty Picture: Experi-
encing Data Through interactive Visual Explorations”);
Yana Bromberg, Assistant Professor at the Department of
Biochemistry and Microbiology, Rutgers University (title:
“Interpreting genomic data to inform pathogenesis path-
ways”); and Jacque Fetrow, the Provost and Vice President
of Academic Affairs at the University of Richmond (title:
“What do all those proteins do? An approach to function-
ally relevant clustering the protein universe”).
Participants also had the opportunity to attend a spe-
cial workshop on “omics in bioinformatics”. The presen-
ters in the workshop were Thomas Girke, Director of the
Bioinformatics Facility in the Institute of Integrative Gen-
ome Biology at University of California, Riverside (title:
“Computational Genomics”); Alexey I. Nesvizhskii,
Associate Professor in the Department of Computational
Medicine & Bioinformatics and Pathology at the Univer-
sity of Michigan, Ann Arbor (title: “Computational Pro-
teomics”); and Frank Emmert-Streib, Associate Professor
at the Center for Cancer Research and Cell Biology,
Queen’s University Belfast (title: “Computational Tran-
scriptomics”). Participants also had chance to attend
pre-conference workshop on “R and Bioconductor” by
Dr. Girke.
The winners of conference awards were:
Best Paper Award: “Efficient experimental design for
uncertainty reduction in gene regulatory networks” by
Roozbeh Dehghannasiri, Byung-Jun Yoon and Edward
Dougherty [1].
Best Oral Presentations (Post-Doctoral fellows):
William S. Sanders, Ph.D., Mississippi State
University
Daniel Mohsenizadeh, Ph.D., Texas A&M University
Hui Wen Ng, Ph.D., National Center for Toxicology
Research, FDA
Best Oral Presentations (students):
Badri Adhikari, University of Missouri
Zhaofang Li, Rush College
Lauren Bright, Mississippi State University
* Correspondence: jonathan-wren@omrf.org
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Best Poster (Computation):
Mihir Jaiswal, University of Arkansas at Little Rock-
1st Place
Jordyn Radke, University of Arkansas at Little Rock-
2nd Place
Jundi Wang, Southern Mississippi University- 3rd
Place
Best Poster (Biology):
Shuneize Slater(Lowe), University of Mississippi- 1st
Place
Lucky Ahmed, Jackson State University- 2nd Place
Lisa Alley, University of Arkansas for Medical
Sciences- 3rd Place
Selecting papers for the MCBIOS XI proceedings
This year, 20 papers were submitted, and 12 papers
were deemed acceptable by reviewers, giving an accep-
tance rate of 60%. All papers were anonymously peer-
reviewed by at least 2 reviewers and quantitatively
ranked on the basis of three evaluation criteria: Novelty
(1-5), Impact (1-5) and Clarity (1-3). Editors that were
co-authors of submitted papers were not permitted to
handle their own papers editorially. Papers generally fell
into three categories:
Networks and pathways
Dehghannasiri et al won this year’s best paper award for
their paper on a method to reduce uncertainty in gene
regulatory networks [1] (GRNs). They accomplish this
by proposing a quantification of the mean objective cost
of uncertainty so that experiments with the least uncer-
tainty become the most highly prioritized. They show
on simulated and real GRNs that their method is close
to the optimal method, but at a lower cost. Because the
computational complexity of analyzing potential GRN
structures becomes increasingly burdensome for each
new node added, methods to speed up computation
enable more accurate approximations.
Mohsenizadeh and colleagues [2] presented a novel
methodology to address the dynamic modeling of geno-
mic networks containing uncertainty due to incomplete
data. The approach can utilize interaction knowledge
provided in public databases. This allows for the con-
struction and study of dynamic interaction-based net-
works that may be based on small sets of available
genomic experimental data.
Huang et al report DMAP [3], an extension of the
connectivity map (CMAP) concept to identify similar
transcriptional effects of drugs upon cell lines. DMAP
incorporates additional data on drug to protein effects
and effect scores. Using the additional data, DMAP
showed increased performance in predicting drug
similarity.
Luo et al predicted the binding of peptide with
Human Leukocyte antigen (HLA) using network analysis
[4]. This analysis was performed to generate more
understanding of adverse drug reactions (ADR) experi-
ence by some patients after taking some drugs. To
understand ADR they coupled the network analysis with
Nebula to predict the binding interaction of peptides
with HLA.
Kim et al identified the genetic subnetwork modules
related to maize defense response to the fungal pathogen
[5]. This analysis was conducted to understand genetic
basis of host (maize) and pathogen (F. verticilloides)
interaction. They used the network based to approach to
identify the maize defense subnetwork activated in pre-
sence of the fungus pathogen F. verticilloides.
Genomics & transcriptomics
Peterson et al present improvements to their CloneViz
software [6] to analyze cancer clonality [7], taking into
account multiple types of data gathered, such as whole
exome sequencing, RNA-seq and methylation status.
They use CloneViz to conduct an analysis of multiple
myeloma samples, comparing biopsies gathered at pre-
sentation and relapse, finding an amplification of a
MYC oncogene with a missense mutation.
Dozmorov et al, [8] present a paper concerning an
interpretation of the effects from adapter trimming,
removal of duplicates, and filtering of low complexity
regions. The results show that all the three processing
steps will improve the data analysis in RNA-seq and
ChIP-seq data in terms of biological signals obtainable
by enrichment analysis.
The manuscript by Dohrmann et al.[9] addresses and
important issue of multiple network alignment, which is
broadly useful for comparing pairwise networks derived
from different sources. The authors developed a Scaffold-
based Multiple Network Aligner (SMAL), which uses a
star-like alignment topology and does not rely on native
multiple network alignment implementations. They
tested SMAL using protein interaction networks from
eight different species and showed that the quality of the
alignments were comparable to native MNA methods
but with much faster performance. The speed and flex-
ibility of SMAL make it ideal for comparison of multiple
large networks derived from an expanding array of omics
platforms.
Miscellaneous
Automated high resolution dermoscopic image analysis
techniques can be very useful in clinical settings by eluci-
dating information that would otherwise be unnoticeable.
Lemon and colleagues [10] parallelized a prominent skin
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lesion border detection algorithm by using the new
WebCL web browser based parallel programming tech-
nology on graphical processing units (GPUs). The parallel
version of the border detection algorithm had the same
accuracy with 4-5 fold faster speeds and provides the
flexibility to run on mobile devices, making it ideal for
use in clinical settings.
Lencioni et al demonstrated the adverse event (AE)
capture management software for cancer studies. [11].
They created this to help with decisions crucial for clini-
cal trials. They used the standards based AE Reporting
System (AERS) in integration with Epic Electronic
Health Record for tracking the current and recent AEs.
This system is currently to supporting the 350 patients
enrolled for around 65 different cancer studies.
In the paper by Zhao and colleagues [12], the authors
presented a heuristic method called Rate of Perplexity
change (RPC) to determine the optimal number of
topics in a collection of text documents after applying
the well-known Latent Dirichlet Allocation (LDA)
method. The RPC method was evaluated on three
widely different data types and sizes and was found to
be stable, accurate and effective.
Madahian et al [13] report a new classification method
and applied it to a microarray gene expression dataset
with comparisons to other classification methods. The
approach employed a Generalized Double Pareto (GDP)
prior to induce sparsity in a Bayesian Generalized Linear
Model and resulted in an improved prostate cancer sub-
class prediction especially with pre-metastatic stages.
Future meetings
Approaches towards applied biomedical science, basic
research and clinical medicine are rapidly changing due
to next generation sequencing (NGS). This is especially
true for cancer-based endeavors and the practice of clin-
ical oncology. President Obama’s Precision Medicine
Initiative calls for a near-term focus on cancers and a
longer-term aim to generate knowledge applicable to a
whole range of health and disease [14]. Why now? Both
goals are within reach due to i) advances in genomics
over the past 10 years, ii) increasing use of electronic
health records, iii) technical advances in health devices
in smart phones and the fact a majority of US adults
own one, iv) advances in data science especially con-
cerning big data, and v) the changing role of patient
partnerships especially crowd sourcing and citizen
science, where people want to participate with feedback.
Since the cost of a Whole Exome Sequencing (WES)
study is ~$1000 (the price of a CT scan), NGS assays
are expected to proliferate and become the standard of
care in the future. Implementation of precision medicine
into the clinical workflow requires significant changes in
infrastructure, work force development and logistics.
The vital infrastructure involves advanced analytics
including decision support, information technology and
high-performance computing capabilities. A precision
medicine clinic would have to seamlessly integrate
patient genetic counseling, sample collection, storage,
sequencing, analysis and secure delivery of genomic-
based information to the physician at the point of care
[15]. So, what exactly is precision medicine?
Precision medicine is an innovative approach that takes
into account individual differences in people’s genes,
environments, and lifestyles. It gives medical profes-
sionals the resources they need to target treatments,
improve outcomes, and reduce side effects. In oncology,
the ultimate aim of precision medicine is to keep people
healthier by detecting cancer earlier, using an individual
(versus categorical) approach for therapeutic assign-
ments, and reducing therapeutic related toxicities. Cancer
precision medicine uses genetic information from a
patient’s tumor to determine a rationally derived therapy
plan targeted to the particular genetic abnormality. It is
also furthering the study of correlations and associations
of cancer patients in terms of: i) genotype to phenotype
and ii) phenotype to genotype. By using individual
genetic information to prevent, diagnose earlier, and
treat disease/cancer with better precision, this type of
genomics-enabled medicine promises health care that is
personalized, more predictive, and preventive rather than
reactive. In summary, precision medicine targets the
needs of individual patients on the basis of genetic, bio-
marker, phenotypic, or psychosocial characteristics that
customize care. Precision medicine approaches will be
judged by rigorous evaluation of “providing value” via
analyses of i) efficacy, ii) safety, and iii) cost effectiveness
[16]. Please join us for MCBIOS 2016 from March 3rd-5th
in Memphis, Tennessee where precision medicine will be
the conference theme.
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